A single significantly appealing compound is LDN-27219. Though most tTG inhibitors are built to bind to your protein crosslinking active site, LDN-27219 instead binds for the nucleotide binding pocket from the enzyme while it is actually in its closed-point out conformation, and stabilizes that conf